Apoptosis of human neuroblastoma cells induced by liposome-encapsulated Fenretinide

Journal of Liposome Research

Volumn 8, Issue 3, 1998, Pages 401-423

  Pagnan, Gabriella ^a   Caridi, Gianluca ^a   Montaldo, Paolo G ^a   Bado, Massimo ^a   Chiesa, Valeria ^a   Allen, Theresa M ^b   Ponzoni, Mirco ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Apoptosis; Fenretinide; Liposomes; Neuroblastoma

Indexed keywords

FENRETINIDE; LIPOSOME;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CYTOSTASIS; DNA DEGRADATION; DNA STRAND BREAKAGE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG HALF LIFE; GENE ACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

EID: 0031706665     PISSN: 08982104     EISSN: None     Source Type: Journal    
DOI: 10.3109/08982109809035543     Document Type: Article

References (61)

1. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
2. Steller, H. 1995. Mechanisms and genes of cellular suicide. Science 267:1445-1449.
3. Burek, M.J., and Oppenheim R.W. 1996. Programmed cell death in the developing nervous system. Brain Pathol 6:427-446.
4. Marx, J. 1993. Cell death studies yield cancer clues. Science 259:760-761.
5. Dive, C. and Hickman, J.A. 1991. Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer 64:192-196.
6. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
7. Smith, M.A., Parkinson, D.R., Cheson, B.D., and Friedman, M.A. 1992. Retinoids in cancer therapy. J Clin Oncol 10:839-864.
8. Smith, M.A., Adamson, P.C., Balis, F.M., Feusner, J., Aronson, L., Murphy, R.F., Horowitz, M.E., Reaman, G., Hammond, G.D., Fenton, R.M., Connagjan, G.D., Hittelman W.N., and Poplack, D.G. 1992. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer. J Clin Oncol 10:1666-1673.
9. Moon, R.C., Thompson, H.J., Becci, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen, L.T., Brown, C.C., and Sporn, M.B. 1979. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res 39:1339-1346.
10. Moon, R.C., Mehta, R.G., and Detrisac, C.J. 1992. Retinois as chemopreventive agents for breast cancer. Cancer Res 39:73-79.
11. Pollard, M., and Luckert, P.H. 1991. The inhibitory effect of 4-hydroxyphenylretinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats. Cancer Lett 59:159-163.
12. Bhatnagar, R., Abou-Issa, H., Curley, R.W. Jr, Koolemans-Beynen, A., Moeschberger, M. L., and Webb, T.E. 1991. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. Biochem Pharmacol 41:1471-1472.
13. Delia, D., Aiello, A., Lombardi, L., Pelicci, P.O., Grignani, F., Grignani, F., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U., and Pierotti, M.A. 1993. N-(4-Hydroxyphenyl)retinamide (HPR) induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 53:6036-6041.
14. Supino, R., Crosti, M., Clerici, M., Warlters, A.S., Cleris, L., Zunino, F., Formelli, F. 1996. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int J Cancer 65:491-497.
15. Kalemkerian, G.P., Slusher, R., Ramalingam, S., Gadgeel, S., Mabry, M. 1995. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. J Natl Cancer Inst 87:1674-1680.
16. Ponzoni, M., Bocca, P., Chiesa, V., Decensi, A., Pistoia, V., Raffaghello, L., Rozzo, C. and Montaldo, P.G. 1995. Differential effects of N-(4-Hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res 55:853-861.
17. Allen, T.M. 1994. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. TiPS 15:215-220.
18. Lasic, D.D., Papahadjopoulos, D. 1995. Liposomes revisited. Science 26:1275-1276.
19. Lasic, D.D. 1996. Doxorubicin in sterically stabilized liposomes. Nature 380:561-562.
20. Allen, T.M., Hansen, C., Martin, F., Redemann, C., and Yau-Young, A. 1991. Liposomes containing synthetic lipid derivates of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et Biophysica Acta 1066:29-36.
21. Szoka, F., and Papahadjopoulos, D. Liposomes: preparation and characterization in Liposomes: From Physical Structure to Therapeutic Applications. C. G. Knigth (ed.), Elsevier/North-Holland Biomedical Press, Amsterdam/New York. 1991.
22. Biedler, J.L., Helson, L., and Spengler, B.A. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33:2643-2652.
23. Biedler, J.L., Roffer-Tarlov, S., Schachner, M., and Freedman, L.S. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38:3751-3757.
24. Tumilowicz, J.J., Nichols, W.W., Cholon, J.J., and Greene, A. 1970. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30:2110-2118.
25. Gross, N., Beck, D., Portoukalian, J., Favre, S., and Carrel, S. 1989. New anti-GD2 monoclonal antibodies produced from gamma-interferon-treated neuroblastoma cells. Int J Cancer 43:665-671.
26. Matsushima, H., and Bogenmann, E. 1992. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro. Int J Cancer 51:250-258.
27. Longo, L., Christiansen, H., Christiansen, N.M., Paulsen, P., Cornagli-Ferraris, P., and Lampert, F. 1988. N-myc amplification at chromosome band 1p32 in neuroblastoma cells as investigated by in situ hybridization. J Cancer Res Clin Oncol 114:636-640.
28. Cornaglia-Ferraris, P., Ponzoni, M., Montaldo, P., Mariottini, G.L., Donti, E., Di Martino, D., and Tonini, G. 1990. A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-myc. Pediat Res 27:1-6.
29. Cornaglia-Ferraris, P., Sansone, R., Mariottini, G.L., Longo, L., and Tonini, G. 1990 (b). Evidence of loss of N-myc amplification during the establishment of a human neuroblastoma cell line. Int J Cancer 45:578-579.
30. Seeger, R.C., Danon, Y.L., Rayner, S.A., and Hoover, F. 1982. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 128:983-989.
31. Hultin, T.A., Mehta, R.G., and Moon, R.C. 1985. Simple high performance liquid chromatographic method for the separation of retinoids including N-(4-hydroxyphenyl)-all-trans-retinamide. J Chromatogr 341:187-192.
32. Formelli, F., Carsana, R., Costa, A., Buranelli, F., Campa, T., Dossena, G., Magni, A., and Pizzichetta, M. 1989. Plasma retinol level reduction by the synthetic retinoid Fenretinide: a one year follow-up study of breast cancer patients. Cancer Res 49: 6149-6154.
33. Jacobson, M.D., Burne, J.F., King, M.P., Miyashita, T., Reed, J., and Raff, M.C. 1993. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361:365-369.
34. Matzinger, P. 1981. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Meth 145:185-188.
35. Nicoletti, I., Migliorati, G., Pagliacci, M.C., Grignani, F., Riccardi, C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 139:271-275.
36. Formelli, F., Clerici, M., Campa, T., Di Mauro, M.G., Magni, A., Mascotti, G., Moglia, D., De Palo, G., and Costa, A. 1993. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol 11: 2036-2042.
37. Peng, Y.M., Dalton, W.S., Albberts, D.S., Xu, M.J., Lim, H., Meyskens, F.L. Jr. 1989. Pharmakinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients. Int J Cancer 43: 22-26.
38. Wyllie, A.H., Kerr, J F.R., and Currie, A.R. 1980. Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
39. Chan, L.-N., Zhang, S., Shao, J., Waikel, R., Thompson, E.A., and Chan, T.-S. 1997. N-(4-hydroxyphenyl) retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells. Leukemia and Lymphoma 25:271-280.
40. De Bernardi, B., Rogers, D., Carli, M., Madon, E., De Laurentis, T., Bagnulo, S., Di Tullio, M., Paolucci, G., and Pastore, G. 1987. Localized neuroblastoma. Cancer (Phila.) 60:1066-1072.
41. Philip, T., Ladenstein, R., Zucker, J.M., Pinkerton, R., Bouffet, E., Louis, D., Siegert, W., Bernard, J.L., Frappaz, D., Coze, C., Wyss, M., Beck, D., Souillet, G., Michon, J., Philip, I., Chauvin, F., Favrot, M., and Biron, P. 1993. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study. Br J Cancer 67:119-127.
42. Pritchard, J. 1995. Megatherapy for advanced neuroblastoma - Rationale and Role. Eur J Cancer 31A:134-136.
43. Garaventa, A., Rondelli, R., Lanino, E., Dallorso, S., Dini, G., Bonetti, F., Arrighini, A., Santoro, N., Rossetti, F., Miniero, R., Andolina, M., Amici, A., Indolfi, P., Lo Curto, M., Favre, C., Paolucci, P., Pession, A., and De Bernardi, B. for the Italian Association of Pediatric Hematology-Oncology, BMT Group. 1996. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian bone marrow transplant Registry. Bone Marrow Transpl 18:125-130.
44. D'Angio, G.J., Evans, A.E., and Koop, C.E. 1971. Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1:1046-1049.
45. Haas, D., Ablin, A.R., Miller, C., Zoger, S., and Matthay, K.K. 1988. Complete pathologic maturation and regression of stage IV-S neuroblastoma without treatment. Cancer 62:818-825.
46. Hanada, M., Krajewski, S., Tanaka, S., Cazals-Hatem, D., Spengler, B.A., Ross, R.A., Biedler, J.L., and Reed, J.C. 1993. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells. Cancer Res 53:4978-4986.
47. Goldstein, P., Ojcius, D.M., and Young, J.D. 1991. Cell death mechanisms and immune system. Immunol Rev 121:29-65.
48. Williams, G.T. 1991. Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098.
49. Gestblom, C., Hoener, J.C., Påhlman, S. 1995. Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index. Eur J Cancer 31A:458-463.
50. Moon, R.C., Mehta, R.G., Rao, K.V. Retinoids and cancer in experimental animals in The retinoids: biology, chemistry, and medicine. Sporn, M.B., Roberts, A.B., Goodman, D.S., (Eds.), pp.573-596, Raven Press, New York. 1994.
51. Modiano, M.R., Dalton, W.S., Lippman, S.M., Joffe, L., Booth, A.R., Meyskens, F.L. Jr. 1990. Phase II study of fenretinide (N-(4-Hydroxyphenyl)retinamide) in advanced breast cancer aand melanoma. Invest New Drags 8:17-19.
52. Fanjul, A.N., Delia, D., Pierotti, M.A., Rideout, D., Qiu, J., Pfahl, M. 1996. N-4-Hydroxyphenyl Retinamide is a highly selective activator of retinoid receptors. J Biol Chemiistry 271:22441-22446.
53. Yuan, F., Leunig, M., Huang, S.K., Berk, D.A., Papahadjopoulos, D., and Jain, R.K. 1994. Microvascular permeability and interstitial penetration of sterically stabilizied (Stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352-3356.
54. Wu, Z.N., Da, D., Rudoll, T.L., Needham, D., Whorton, R., Dewhirst, M.W. 1993. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 53:3765-3770.
55. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F. 1994. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987-992.
56. Piacentini, M., Annichiarico-Petruzzelli, M., Oliverio, S., Piredda, L., Biedler, J., and Melino, G. 1992. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int J Cancer 52:271-278.
57. Montaldo, P.G., Chiesa, V., Bado, M., Raffaghello, L., Rozzo, C., Ponzoni, M. 1997. Induction of differentiation and apoptosis by interferon-γ in human neuroblastoma cells in vitro as a dual and alternative early biological response. Cell Death and Differentation 4:150-158.
58. Chen, J-Y, Clifford, J., Zusi, C., Starrett, J., Tortolani, D., Ostrowski, J., Gronemeyer, H. 1996. Two distinct actions of retinoid-receptor ligands. Nature 382:819-822.
59. Horn, V., Minucci, S., Ogryzko, V.V., Adamson, E.D., Howard, B.H., Levin, A.A., Ozato, K. 1996. RAR and RXR selective lingands cooperatively induce apoptosis and neuronal differentation in P19 embryonal carcinoma cells. The FASEB J 10: 1071-1077.
60. Fanjul, A.N., Bouterfa, H., Pfahl, M. 1996. Potential role of retinoic acird receptor-(in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res 56:1571-1577.
61. Means, A.L., and Gudas, L.J. 1995. The roles of retinoids in vertebrate development. Annu Rev Biochem, 64:201-233.